Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tscan Therapeutics Inc (TCRX)

Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tscan Therapeutics Inc 830 WINTER STREET WALTHAM MA 02451 USA

www.tscan.com P: 857-399-9500

Description:

TScan Therapeutics Inc. is a biopharmaceutical company. It focused on the development of T-cell receptor engineered T cell therapies for the treatment of patients with cancer. The company's lead product pipeline consist TSC-100 and TSC-101. TScan Therapeutics Inc. is based in WALTHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 340,920
Enterprise Value, $K 237,610
Shares Outstanding, K 47,882
Annual Sales, $ 21,050 K
Annual Net Income, $ -89,220 K
Last Quarter Sales, $ 7,210 K
Last Quarter Net Income, $ -19,610 K
EBIT, $ -93,460 K
EBITDA, $ -88,100 K
60-Month Beta 0.90
% of Insider Shareholders 8.27%
% of Institutional Shareholders 82.83%
Float, K 43,922
% Float 91.73%
Short Volume Ratio 0.35

Growth:

1-Year Return 193.93%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 03/06/24
Latest Earnings Date 05/08/24
Earnings Per Share ttm -1.89
EPS Growth vs. Prev Qtr 12.50%
EPS Growth vs. Prev Year 73.08%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TCRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -60.65%
Return-on-Assets % -33.86%
Profit Margin % -423.85%
Debt/Equity 0.20
Price/Sales 15.51
Price/Cash Flow N/A
Price/Book 2.19
Book Value/Share 3.15
Interest Coverage -22.73
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar